Pharmaceutical Preparations · DE · CIK 1453687
Pioneering cell therapy for autoimmune diseases using proprietary mRNA technology
Comparable business profile · signals at a glance
In the 90 days to Jan 6, 2026: 1 insider bought $206K · 3 sold $259K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2026 | Brunn CarstenPresident and CEO | Sell | 23,766 | $6.82 | $162K |
| Jan 6, 2026 | Davis BlaineChief Financial Officer | Sell | 10,591 | $6.82 | $72K |
| Jan 6, 2026 | Miljkovic MilosChief Medical Officer | Sell | 3,573 | $6.82 | $24K |
| Dec 4, 2025 | Barabe Timothy CDirector | Buy | 30,000 | $6.86 | $206K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.